DiscoverTreating TogetherS5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander
S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander

S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander

Update: 2024-10-31
Share

Description

In this episode of Targeted Talks, Seth Wander, MD, PhD, medical oncologist at Massachusetts General Hospital and assistant professor at Harvard Medical School, discusses the clinical importance of ESR1 mutations in hormone receptor-positive metastatic breast cancer and how these mutations influence treatment approaches.




Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander

S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander

Targeted Oncology